Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: August 8, 2022

Investigational Drug Information for Talinolol

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the drug development status for Talinolol?

Talinolol is an investigational drug.

There have been 4 clinical trials for Talinolol. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1^st 2007.

The most common disease conditions in clinical trials are Obesity, Morbid and [disabled in preview]. The leading clinical trial sponsors are University Medicine Greifswald, Matthias Schwab, and Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH.

Summary for Talinolol

US Patents	0
International Patents	0
US Patent Applications	784
WIPO Patent Applications	483
Japanese Patent Applications	2
Clinical Trial Progress	Phase 1 (2007-06-01)
Vendors	46

Recent Clinical Trials for Talinolol

Title	Sponsor	Phase
Open Label Study for the Functional Characterization of Drug Metabolism and Transport	Matthias Schwab	Phase 1
Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water	University Medicine Greifswald	Phase 1
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics	Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH	Phase 1

See all Talinolol clinical trials

Clinical Trial Summary for Talinolol

Top disease conditions for Talinolol

Top clinical trial sponsors for Talinolol

See all Talinolol clinical trials

US Patents for Talinolol

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Express Scripts

Merck

Medtronic

Colorcon

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.